Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. 1998

H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
Department of Hematology and Oncology, Osaka University Medical School, Suita city, Osaka 565, Japan.

The chronic fatigue syndrome (CFS) is a condition of unknown etiology, characterized by a persistent debilitating fatigue, the muscle-related symptoms and the neuropsychiatric symptoms. Recently, it has been reported that the patients with CFS might have impaired activation of the hypothalamic-pituitary-adrenal axis, and suggested that a part of the patho-genesis of CFS might be associated with abnormalities of the endocrine system. Herein, we show that the majority of Japanese patients with CFS had a serum dehydroepiandrosterone sulfate (DHEA-S) deficiency. Serum DHEA-S is one of the most abundantly produced hormones which is secreted from the adrenal glands, and its physiological function is thought to be a precursor of sex steroids. DHEA-S has recently been shown to have physiological properties, such as neurosteroids, which are associated with such psychophysiological phenomena as memory, stress, anxiety, sleep and depression. Therefore, the deficiency of DHEA-S might be related to the neuropsychiatric symptoms in patients with CFS.

UI MeSH Term Description Entries
D008297 Male Males
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015065 17-Hydroxycorticosteroids A group of hydroxycorticosteroids bearing a hydroxy group at the 17-position. Urinary excretion of these compounds is used as an index of adrenal function. They are used systemically in the free alcohol form, but with esterification of the hydroxy groups, topical effectiveness is increased. 17 Hydroxycorticosteroids
D015068 17-Ketosteroids Steroids that contain a ketone group at position 17. 17-Oxosteroids,17 Ketosteroids,17 Oxosteroids
D015673 Fatigue Syndrome, Chronic A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9) Chronic Fatigue Syndrome,Encephalomyelitis, Myalgic,Infectious Mononucleosis-Like Syndrome, Chronic,Postviral Fatigue Syndrome,Chronic Fatigue Disorder,Chronic Fatigue and Immune Dysfunction Syndrome,Chronic Fatigue-Fibromyalgia Syndrome,Myalgic Encephalomyelitis,Royal Free Disease,Systemic Exertion Intolerance Disease,Chronic Fatigue Disorders,Chronic Fatigue Fibromyalgia Syndrome,Chronic Fatigue Syndromes,Chronic Fatigue-Fibromyalgia Syndromes,Fatigue Disorder, Chronic,Fatigue Syndrome, Postviral,Fatigue Syndromes, Chronic,Fatigue-Fibromyalgia Syndrome, Chronic,Fatigue-Fibromyalgia Syndromes, Chronic,Infectious Mononucleosis Like Syndrome, Chronic,Postviral Fatigue Syndromes,Syndrome, Postviral Fatigue

Related Publications

H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
September 2009, Psychiatry investigation,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
December 1984, The Journal of clinical endocrinology and metabolism,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
January 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
April 1988, Lancet (London, England),
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
October 2005, Neuro endocrinology letters,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
March 1965, Casopis lekaru ceskych,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
January 1965, Endokrinologie,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
April 1999, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
January 1988, Lancet (London, England),
H Kuratsune, and K Yamaguti, and M Sawada, and S Kodate, and T Machii, and Y Kanakura, and T Kitani
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!